Gene · 710
Papers4,575
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 4,575
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Hereditary angioedema diagnosis evaluation score (HADES): A new clinical scoring system for predicting hereditary angioedema with C1 inhibitor deficiency. | J Allergy Clin Immunol Glob | 2025 | 39991622 | PubTator, text mining | PubMed |
| De Novo or inherited: gonosomal mosaicism in hereditary angioedema due to C1 inhibitor deficiency. | Front Immunol | 2025 | 39981253 | PubTator, text mining | PubMed |
| Omics data integration analysis identified new biological insights into chronic antibody-mediated rejection (CAMR). | J Transl Med | 2025 | 39979925 | PubTator, text mining | PubMed |
| Perioperative C1-esterase inhibitor therapy to allow transplantation in a highly sensitized lung transplant candidate: Three case reports. | Am J Transplant | 2025 | 39978596 | PubTator, text mining | PubMed |
| Sequence-structure based prediction of pathogenicity for amino acid substitutions in proteins associated with primary immunodeficiencies. | Front Immunol | 2025 | 39975544 | PubTator, text mining | PubMed |
| Integrative transcriptomic and proteomic analysis reveals that SERPING1 inhibits neuronal proliferation via the CaMKII-CREB-BDNF pathway in schizophrenia. | World J Psychiatry | 2025 | 39974493 | PubTator, text mining | PubMed |
| WNT inhibitor SP5-mediated SERPING1 suppresses lung adenocarcinoma progression via TSC2/mTOR pathway. | Cell Death Dis | 2025 | 39962118 | PubTator, text mining | PubMed |
| Anaesthesetic considerations in the perioperative management of patients with hereditary angioedema-FXII. | Rev Esp Anestesiol Reanim (Engl Ed) | 2025 | 39961533 | PubTator, text mining | PubMed |
| Early diagnosis of hereditary angioedema in children: genetic testing should be prioritized. | Allergy Asthma Clin Immunol | 2025 | 39934904 | PubTator, text mining | PubMed |
| Complement function and activation in human serum and plasma collected in different blood collection tubes. | J Immunol Methods | 2025 | 39921078 | PubTator, text mining | PubMed |
| Correction To: Uncovering a novel SERPING1 pathogenic variant: insights into the aggregation of C1-INH in hereditary angioedema. | Orphanet J Rare Dis | 2025 | 39915882 | PubTator, text mining | PubMed |
| Integrated Approach for Biomarker Discovery and Mechanistic Insights into the Co-Pathogenesis of Type 2 Diabetes Mellitus and Non-Hodgkin Lymphoma. | Diabetes Metab Syndr Obes | 2025 | 39906693 | PubTator, text mining | PubMed |
| A Case of Status Epilepticus in a Patient Experiencing an Acute Attack of Hereditary Angioedema. | Clin Pract Cases Emerg Med | 2025 | 39903629 | PubTator, text mining | PubMed |
| Biomarkers predicting postoperative adverse outcomes in children with congenital heart disease: a systematic review and meta-analysis. | Front Pediatr | 2025 | 39896721 | PubTator, text mining | PubMed |
| Integrated Analysis of Bulk RNA Sequencing, eQTL, GWAS, and Single-Cell RNA Sequencing Reveals Key Genes in Hepatocellular Carcinoma. | J Cell Mol Med | 2025 | 39853609 | PubTator, text mining | PubMed |
| Specialty laboratory testing for chronic abdominal pain in irritable bowel syndrome. | Scand J Gastroenterol | 2025 | 39853154 | PubTator, text mining | PubMed |
| Identification of a novel mutation in the SERPING1 gene in a 17-year-old Chinese girl with type I hereditary angioedema. | JAAD Case Rep | 2025 | 39839458 | PubTator, text mining | PubMed |
| Indirect treatment comparison of lanadelumab and a C1-esterase inhibitor in pediatric patients with hereditary angioedema. | J Comp Eff Res | 2025 | 39836016 | PubTator, text mining | PubMed |
| Discovery of novel serum peptide biomarkers for cholangiocarcinoma recurrence through MALDI-TOF MS and LC-MS/MS peptidome analysis. | Sci Rep | 2025 | 39833435 | PubTator, text mining | PubMed |
| Worldwide Prevalence of Hereditary Angioedema: A Systematic Review and Meta-Analysis. | Int Arch Allergy Immunol | 2025 | 39827848 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/710/papers?page=11